FindTrial
Sign In

Technology Transfer Application Research: Clinical Observation of Medicinal Therapy for Primary Dysmenorrhea (Cold Coagulation and Blood Stasis Syndrome)

Technology Transfer Application Research: Clinical Observation of Medicinal Therapy for Primary Dysmenorrhea (Cold Coagulation and Blood Stasis Syndrome)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002643
Enrollment
Unknown
Registered
2025-12-30
Start date
2024-12-08
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea

Interventions

Experimental Group:Medicinal
Control Group:Simple moxibustion

Sponsors

Liaoning University of Traditional Chinese Medicine Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: (1) Patients who meet the diagnostic criteria for primary dysmenorrhea (cold coagulation and blood stasis syndrome) in both traditional Chinese and Western medicine; (2) Patients aged between 18 and 35 years old; (3) Patients with a regular menstrual cycle, averaging 21-35 days, and a menstrual period lasting 3-7 days; (4) Patients with a visual analog scale score of =4 points; (5) Patients who have been informed, voluntarily agree to participate in the study, are willing to bear the related costs, and sign the relevant documents.

Exclusion criteria

Exclusion criteria: (1) Confirmed cases of secondary dysmenorrhea, such as adenomyosis, endometriosis, or pelvic inflammatory diseases; (2) Individuals allergic to drug components or moxibustion; (3) Local skin ulcers or skin injuries; (4) Patients with severe underlying diseases of the cardiovascular, hepatic, renal, gastrointestinal, or hematological systems, or mental disorders; (5) Women who are planning pregnancy, pregnant, or breastfeeding; (6) Individuals who have participated in other clinical trials within the past three months.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;—

Secondary

MeasureTime frame
Hamilton Depression Rating Scale (HAMD) Score;COX Dysmenorrhea Symptom Rating Scale;Laboratory biochemical indicators: Tumor Necrosis Factor Alpha (TNF-a), Prostaglandin F2a (PGF2a), Prostaglandin E2 (PGE2), Interleukin-10 (IL-10), Vasopressin.;Pain Duration;The World Health Organization Quality of Life Assessment Scale Short Form (WHOQOL-BREF Scale);Pain Relief Rate;Traditional Chinese Medicine Syndrome Score;Recurrence rate of dysmenorrhea;The usage rate of analgesics.;—

Countries

China

Contacts

Public ContactWang Xin

Liaoning University of Traditional Chinese Medicine Affiliated Hospital

tmwxtsy@sohu.com18102456588

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026